{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:25:47Z","timestamp":1790630747166,"version":"4.1.0"},"update-to":[{"DOI":"10.1371\/journal.ppat.1007643","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000}}],"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T00:00:00Z","timestamp":1551657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1007643","type":"journal-article","created":{"date-parts":[[2019,3,4]],"date-time":"2019-03-04T13:35:04Z","timestamp":1551706504000},"page":"e1007643","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":93,"title":["A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2036-4878","authenticated-orcid":true,"given":"Miguel J.","family":"Rodo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Rozot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1662-4961","authenticated-orcid":true,"given":"Elisa","family":"Nemes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5642-7121","authenticated-orcid":true,"given":"One","family":"Dintwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3491-1809","authenticated-orcid":true,"given":"Mark","family":"Hatherill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0641-1359","authenticated-orcid":true,"given":"Thomas J.","family":"Scriba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,3,4]]},"reference":[{"key":"ref1","unstructured":"World Health Organisation. Global tuberculosis report 2018. Geneva: 2018."},{"issue":"33","key":"ref2","doi-asserted-by":"crossref","first-page":"13980","DOI":"10.1073\/pnas.0901720106","article-title":"Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics","volume":"106","author":"LJ Abu-Raddad","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"43","key":"ref3","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1073\/pnas.1404386111","article-title":"Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries","volume":"111","author":"GM Knight","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.12688\/f1000research.13588.1","article-title":"Progress and challenges in TB vaccine development","volume":"7","author":"G Voss","year":"2018","journal-title":"F1000Res"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/imr.12274","article-title":"T cells and adaptive immunity to Mycobacterium tuberculosis in humans","volume":"264","author":"LD Jasenosky","year":"2015","journal-title":"Immunological Reviews"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3389\/fimmu.2017.01262","article-title":"Polyfunctional CD4(+) T Cells As Targets for Tuberculosis Vaccination","volume":"8","author":"DA Lewinsohn","year":"2017","journal-title":"Front Immunol"},{"issue":"7","key":"ref7","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1371\/journal.pmed.0050145","article-title":"Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations","volume":"5","author":"WA Hanekom","year":"2008","journal-title":"PLoS Med"},{"issue":"4","key":"ref8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4049\/jimmunol.1501996","article-title":"Bacillus Calmette-Guerin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses","volume":"197","author":"S Suliman","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/eji.200939754","article-title":"Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells","volume":"40","author":"TJ Scriba","year":"2010","journal-title":"Eur J Immunol"},{"issue":"7","key":"ref10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV- and\/or Mycobacterium tuberculosis-infected adults","volume":"185","author":"TJ Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1164\/rccm.200910-1484OC","article-title":"The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults","volume":"181","author":"B Abel","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.vaccine.2016.11.023","article-title":"H1:IC31 vaccination is safe and induces long-lived TNF-alpha(+)IL-2(+)CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial","volume":"35","author":"H Mearns","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1164\/rccm.201208-1385OC","article-title":"Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72\/AS01 in South African adults","volume":"188","author":"CL Day","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"32","key":"ref14","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"A Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-2600(18)30077-8","article-title":"Safety and immunogenicity of the novel tuberculosis vaccine ID93+GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase 1 trial","volume":"6","author":"A Penn-Nicholson","year":"2018","journal-title":"The Lancet Respiratory Medicine"},{"key":"ref16","article-title":"Dose optimisation of H56:IC31 vaccine for TB endemic populations: A double-blind, placebo-controlled, dose-selection trial","author":"S Suliman","year":"2018","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jim.2014.12.003","article-title":"Qualification of a whole blood intracellular cytokine staining assay to measure mycobacteria-specific CD4 and CD8 T cell immunity by flow cytometry","volume":"417","author":"BM Kagina","year":"2015","journal-title":"J Immunol Methods"},{"issue":"1\u20132","key":"ref18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jim.2004.06.010","article-title":"Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies","volume":"291","author":"WA Hanekom","year":"2004","journal-title":"J Immunol Methods"},{"issue":"7","key":"ref19","doi-asserted-by":"crossref","first-page":"e1005760","DOI":"10.1371\/journal.ppat.1005760","article-title":"A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans","volume":"12","author":"CS Lindestam Arlehamn","year":"2016","journal-title":"PLoS Pathog"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"e0184563","DOI":"10.1371\/journal.pone.0184563","article-title":"Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population","volume":"12","author":"R Baguma","year":"2017","journal-title":"PLoS One"},{"issue":"33","key":"ref21","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"AK Luabeya","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"ref22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2017.05.012","article-title":"Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis","volume":"21","author":"AO Moguche","year":"2017","journal-title":"Cell Host Microbe"},{"issue":"4","key":"ref23","doi-asserted-by":"crossref","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"RA Seder","year":"2008","journal-title":"Nature Reviews Immunology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","article-title":"The immune response in tuberculosis","volume":"31","author":"A O'Garra","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"ref25","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S2213-2600(15)00435-X","article-title":"Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial","volume":"3","author":"F Spertini","year":"2015","journal-title":"The Lancet Respiratory Medicine"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00439-16","article-title":"Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa","volume":"24","author":"AG Loxton","year":"2017","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"ref27","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0016-2016","article-title":"Human Immunology of Tuberculosis","volume":"5","author":"TJ Scriba","year":"2017","journal-title":"Microbiology Spectrum"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cell.2016.08.072","article-title":"A Functional Role for Antibodies in Tuberculosis","volume":"167","author":"LL Lu","year":"2016","journal-title":"Cell"},{"issue":"2","key":"ref29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1714021","article-title":"Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination","volume":"379","author":"E Nemes","year":"2018","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-1-4939-3572-7_12","article-title":"Promises and Pitfalls of High-Throughput Biological Assays","volume":"1415","author":"G Finak","year":"2016","journal-title":"Methods Mol Biol"},{"issue":"17","key":"ref31","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b Controlled Trial of M72\/AS01E Vaccine to Prevent Tuberculosis","volume":"379","author":"O Van Der Meeren","year":"2018","journal-title":"N Engl J Med"},{"issue":"397","key":"ref32","article-title":"Better bootstrap confidence intervals","volume":"82","author":"B Efron","year":"1987","journal-title":"Journal of the American Statistical Association"},{"issue":"2","key":"ref33","first-page":"757","article-title":"Two guidelines for bootstrap hypothesis testing","volume":"47","author":"P Hall","year":"1991","journal-title":"nternational Biometric Society"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/biomet\/74.3.457","article-title":"Prepivoting to reduce level error of confidence sets","volume":"74","author":"R. Beran","year":"1987","journal-title":"Biometrika"},{"key":"ref35","article-title":"Introduction to robust estimation and hypothesis testing","author":"RR Wilcox","year":"2005"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Y Benjamini","year":"1995","journal-title":"Royal Statistical Society"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1037\/h0071325","article-title":"Analysis of a complex of statistical variables into principal components","volume":"24","author":"H. Hotelling","year":"1933","journal-title":"Journal of Educational Psychology"},{"key":"ref38","first-page":"559","article-title":"One lines and planes of closest fit to systems of points in space","volume":"2","author":"K. Pearson","year":"1901","journal-title":"Philosophical magazine"},{"issue":"3","key":"ref39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/biomet\/58.3.453","article-title":"The biplot graphic display of matrices with application to principal component analysis","volume":"58","author":"KR Gabriel","year":"1971","journal-title":"Biometrika"},{"key":"ref40","article-title":"Understanding biplots","author":"JC Gowers","year":"2010"},{"issue":"9","key":"ref41","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1080\/02664760802185399","article-title":"Measures of fit in principal component and canonical variate analyses","volume":"35","author":"S Gardner-Lubbe","year":"2008","journal-title":"Journal of Applied Statistics"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1007643","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T00:00:00Z","timestamp":1552521600000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1007643","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T06:40:53Z","timestamp":1721025653000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1007643"}},"subtitle":[],"editor":[{"given":"David M.","family":"Lewinsohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,3,4]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1007643","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/452060","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,4]]}}}